- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ochsner Names 2019 Alton Ochsner Award Relating Smoking and Disease Honorees
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities.
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities. The 2019 Alton Ochsner Award Relating Smoking and Disease Award has been bestowed to:
Paul M. Cinciripini, PhD (Professor, Department of Behavioral Science and Director, Tobacco Treatment Program at The University of Texas MD Anderson Cancer Center in Houston, Texas)
Edwin K. Silverman, MD, PhD (Professor of Medicine at Harvard Medical School and Physician, Department of Medicine, Pulmonary and Critical Care at Brigham and Women’s Hospital in Boston, Massachusetts)Each honoree will receive a $7500 honorarium, an award medallion, and a plaque describing key research findings.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
